Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Creanga, Dana"'
Publikováno v:
In The Journal of Sexual Medicine May 2016 13(5):852-859
Autor:
Campbell, Ulka B. *, *, Walker, Alexander M., Gaffney, Michael *, Petronis, Kenneth R. *, Creanga, Dana, Quinn, Sheila *, Klein, Barbara E.K., Laties, Alan M., Lewis, Michael **, Sharlip, Ira D., Kolitsopoulos, Francesca *, Klee, Brian J. *, Mo, Jingping *, Reynolds, Robert F. *
Publikováno v:
In The Journal of Sexual Medicine January 2015 12(1):139-151
Autor:
Shabsigh, Ridwan, Kaufman, Joel, Magee, Michelle, Creanga, Dana, Russell, David, Budhwani, Meeta
Publikováno v:
In Urology 2010 76(2):373-379
Autor:
Mahmud, Ehtisham, Bromberg-Marin, Guilherme, Palakodeti, Vachaspathi, Ang, Lawrence, Creanga, Dana, DeMaria, Anthony N.
Publikováno v:
In Journal of the American College of Cardiology 24 June 2008 51(25):2385-2395
Publikováno v:
BMC Urology, Vol 10, Iss 1, p 18 (2010)
Abstract Background Men with erectile dysfunction often have concurrent medical conditions. Conversely, men with these conditions may also have underlying erectile dysfunction. The prevalence of unrecognized erectile dysfunction in men with comorbidi
Externí odkaz:
https://doaj.org/article/1e7fb9a244994bbaabd6a20d0fcb113b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
BMC Medical Research Methodology, Vol 9, Iss 1, p 55 (2009)
Abstract Background The purpose of this analysis was to characterize the placebo response in antimuscarinic drug trials for OAB, based on changes in commonly-used efficacy endpoints. Methods Placebo arm data for incontinence episodes, micturitions, v
Externí odkaz:
https://doaj.org/article/8d8bc05be80c47f7ab4e66ff67c4d1ef
Publikováno v:
In Gastroenterology May 2018 154(6) Supplement 1:S
Publikováno v:
In Gastroenterology May 2018 154(6) Supplement 1:S
Autor:
Ginsberg, David, Schneider, Tim, Kelleher, Con, Van Kerrebroeck, Philip, Swift, Steven, Creanga, Dana, Martire, Diane L.
Publikováno v:
BJU International, 112(3), 373-385. Wiley
Objective To assess the efficacy of fesoterodine 8 mg vs extended-release (ER) tolterodine 4 mg for overactive bladder (OAB) symptoms in terms of patient-reported outcomes in women and in men. Subjects and Methods Pooled data from two 12-week, random
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::d712e343430a55251664d907dd83890e
https://cris.maastrichtuniversity.nl/en/publications/74703055-2fa1-4b1f-ba5c-47ff7c1e132e
https://cris.maastrichtuniversity.nl/en/publications/74703055-2fa1-4b1f-ba5c-47ff7c1e132e
